Iterum Therapeutics ITRM Stock
Iterum Therapeutics Price Chart
Iterum Therapeutics ITRM Financial and Trading Overview
| Iterum Therapeutics stock price | 0.03 USD |
| Previous Close | 0 USD |
| Open | 0.04 USD |
| Bid | 0.0022 USD x 3000 |
| Ask | 0.04 USD x 100 |
| Day's Range | 0.03 - 0.05 USD |
| 52 Week Range | 0.03 - 1.42 USD |
| Volume | 49.3M USD |
| Avg. Volume | 16.33M USD |
| Market Cap | 1.6M USD |
| Beta (5Y Monthly) | 3.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ITRM Valuation Measures
| Enterprise Value | 25.37M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.045454543 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.0993514 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 65.044 |
| Enterprise Value/EBITDA | -1.313 |
Trading Information
Iterum Therapeutics Stock Price History
| Beta (5Y Monthly) | 3.01 |
| 52-Week Change | -96.96% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.42 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.21 USD |
| 200-Day Moving Average | 0.52 USD |
ITRM Share Statistics
| Avg. Volume (3 month) | 16.33M USD |
| Avg. Daily Volume (10-Days) | 104.9M USD |
| Shares Outstanding | 53.29M |
| Float | 52.37M |
| Short Ratio | 2.36 |
| % Held by Insiders | 0.78% |
| % Held by Institutions | 6.34% |
| Shares Short | 3.07M |
| Short % of Float | 5.80% |
| Short % of Shares Outstanding | 5.75% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1982.30% |
| Gross Margin | 29.74% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -53.27% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 390K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 116K USD |
| EBITDA | -19324000 USD |
| Net Income Avi to Common (ttm) | -26961000 USD |
| Diluted EPS (ttm) | -0.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11M USD |
| Total Cash Per Share (mrq) | 0.21 USD |
| Total Debt (mrq) | 33.74M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.135 |
| Book Value Per Share (mrq) | -0.151 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19514000 USD |
| Levered Free Cash Flow (ttm) | -13851125 USD |
Profile of Iterum Therapeutics
| Country | United States |
| State | N/A |
| City | Dublin |
| Address | 3 Dublin Landings |
| ZIP | D01 C4E0 |
| Phone | 353 1 903 8354 |
| Website | https://www.iterumtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Q&A For Iterum Therapeutics Stock
What is a current ITRM stock price?
Iterum Therapeutics ITRM stock price today per share is 0.03 USD.
How to purchase Iterum Therapeutics stock?
You can buy ITRM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Iterum Therapeutics?
The stock symbol or ticker of Iterum Therapeutics is ITRM.
Which industry does the Iterum Therapeutics company belong to?
The Iterum Therapeutics industry is Biotechnology.
How many shares does Iterum Therapeutics have in circulation?
The max supply of Iterum Therapeutics shares is 53.29M.
What is Iterum Therapeutics Price to Earnings Ratio (PE Ratio)?
Iterum Therapeutics PE Ratio is 0.00000000 now.
What was Iterum Therapeutics earnings per share over the trailing 12 months (TTM)?
Iterum Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Iterum Therapeutics company belong to?
The Iterum Therapeutics sector is Healthcare.
Iterum Therapeutics ITRM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}